This session will review recent changes to the market environment for generic and biosimilar medicines in Canada, as well as opportunities to drive even greater value for plan sponsors and beneficiaries. 

Speaker: 

Jim Keon, President of the Canadian Generic Pharmaceutical Association and President of Biosimilars Canada